The impact of growth hormone/insulin-like growth factor-I axis and nocturnal breathing disorders on cardiovascular features of adult patients with Prader-Willi syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 10, 2005, Pages 5639-5646

  Marzullo, Paolo ^a   Marcassa, Claudio ^b   Campini, Riccardo ^b   Eleuteri, Ermanno ^b   Minocci, Alessandro ^a   Priano, Lorenzo ^a   Temporelli, Pierluigi ^b   Sartorio, Alessandro ^a   Vettor, Roberto ^c   Liuzzi, Antonio ^a   Grugni, Graziano ^a  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DOBUTAMINE; GROWTH HORMONE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADRENERGIC STIMULATION; ARTICLE; BODY MASS; BREATHING DISORDER; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CHRONOTROPISM; CLINICAL FEATURE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIASTOLE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOCARDIOGRAPHY; GENDER; GEOMETRY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART RATE; HOMEOSTASIS; HORMONE ACTION; INSULIN RESISTANCE; MULTIVARIATE ANALYSIS; OBESITY; OXYGEN SATURATION; POLYSOMNOGRAPHY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; RISK FACTOR; SCINTIANGIOGRAPHY; SYSTOLE;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; BODY MASS INDEX; ECHOCARDIOGRAPHY; FEMALE; HEART; HEMODYNAMIC PROCESSES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MYOCARDIUM; OBESITY; POLYSOMNOGRAPHY; PRADER-WILLI SYNDROME; RADIONUCLIDE ANGIOGRAPHY; SLEEP APNEA SYNDROMES;

EID: 26244446763     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-0829     Document Type: Article

References (46)

1. Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenberg F 1993 Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 91:398-402
2. Cassidy SB 1997 Prader-Willi syndrome. J Med Genet 34:917-923
3. Nicholls RD 2000 The impact of genomic imprinting for neurobehavioral and developmental disorders. J Clin Invest 105:413-418
4. Brambilla P, Bosio L, Manzoni P, Pietrobelli A, Beccaria L, Chiumello G 1997 Peculiar body composition in patients with Prader-Labhart-Willi syndrome. Am J Clin Nutr 65:1369-1374
5. Hoybye C, Hilding A, Jacobsson H, Thoren M 2002 Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity. J Clin Endocrinol Metab 87:3590-8597
6. Goldstone AP, Thomas EL, Brynes AE, Bell JD, Frost G, Saeed N, Hajnal JV, Howard JK, Holland A, Bloom SR 2001 Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab 86:4330-4338
7. Talebizadeh Z, Butler MG 2005 Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects. Clin Genet 67:230-239
8. Bray GA, Dahms WT, Swerdloff RS, Fiser RH, Atkinson RL, Carrel RE 1983 The Prader-Willi syndrome: a study of 40 patients and a review of the literature. Medicine (Baltimore) 62:59-80
9. Greenswag LR 1987 Adults with Prader-Willi syndrome: a survey of 232 cases. Dev Med Child Neurol 29:145-152
10. Hertz G, Cataletto M, Feinsilver SH, Angulo M 1993 Sleep and breathing patterns in patients with Prader Willi syndrome (PWS): effects of age and gender. Sleep 16:366-371
11. Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H 2001 Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one U.K. health region. J Med Genet 38:792-798
12. Smith A, Loughnan G, Steinbeck K 2003 Death in adults with Prader-Willi syndrome may be correlated with maternal uniparental disomy. J Med Genet 40:e63
13. Schrander-Stumpel CT, Curfs LM, Sastrowijoto P, Cassidy SB, Schrander JJ, Fryns JP 2004 Prader-Willi syndrome: causes of death in an international series of 27 cases. Am J Med Genet A 124:333-338
14. Stevenson DA, Anaya TM, Clayton-Smith J, Hall BD, Van Allen MI, Zori RT, Zackai EH, Frank G, Clericuzio CL 2004 Unexpected death and critical illness in Prader-Willi syndrome: report of ten individuals. Am J Med Genet A 124:158-164
15. Vogels A, Van Den Ende J, Keymolen K, Mortier G, Devriendt K, Legius E, Fryns JP 2004 Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders. Eur J Hum Genet 12:238-240
16. Grugni G, Guzzaloni G, Moro D, Bettio D, De Medici C, Morabito F 1998 Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome. Clin Endocrinol (Oxf) 48:769-775
17. Eiholzer U, Stutz K, Weinmann C, Torresani T, Molinari L, Prader A 1998 Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome. Eur J Pediatr 157:890-893
18. Corrias A, Bellone J, Beccaria L, Bosio L, Trifiro G, Livieri C, Ragusa L, Salvatoni A, Andreo M, Ciampalini P, Tonini G, Crino A 2000 GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology. J Endocrinol Invest 23:84-89
19. Lee PD 2000 Effects of growth hormone treatment in children with Prader-Willi syndrome. Growth Horm IGF Res 10(Suppl B): S75-S79
20. de Boer H, Blok GJ, Van der Veen EA 1995 Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16:63-86
21. Evans LM, Davies JS, Goodfellow J, Rees JA, Scanlon MF 1999 Endothelial dysfunction in hypopituitary adults with growth hormone deficiency. Clin Endocrinol (Oxf) 50:457-464
22. Colao A, Marzullo P, Di Somma C, Lombardi G 2001 Growth hormone and the heart. Clin Endocrinol (Oxf) 54:137-154
23. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML 2002 Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 87:2067-2079
24. Sahn DJ, DeMaria A, Kisslo J, Weyman A 1978 Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072-1083
25. Devereux RB, Reichek N 1977 Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613-618
26. Marcassa C, Galli M, Campini R, Marzullo P, Giannuzzi P 2003 Differential systolic and diastolic effects of β-adrenergic stimulation in patients with severe left ventricular dysfunction: a radionuclide ventriculographic study. J Nucl Cardiol 10:46-50
27. Colao A, Cerbone G, Pivonello R, Aimaretti G, Loche S, Di Somma C, Faggiano A, Corneli G, Ghigo E, Lombardi G 1999 The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. J Clin Endocrinol Metab 84:1277-1282
28. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H 1996 A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 19:1138-1141
29. Butler MG, Fogo AB, Fuchs DA, Collins FS, Dev VG, Phillips 3rd JA 1988 Two patients with ring chromosome 15 syndrome. Am J Med Genet 29:149-154
30. Ahmad MU, Choy YS, Hung LC, Tan SK, Malinee T, Tan SK 2001 Dilated cardiomyopathy in two infants with Prader-Willi syndrome and cytogenetically visible microdeletion of 15q11-q14. Am J Hum Genet 69:S282 (Abstract)
31. Tumer Z, Harboe TL, Blennow E, Kalscheuer VM, Tommerup N, Brondum-Nielsen K 2004 Molecular cytogenetic characterization of ring chromosome 15 in three unrelated patients. Am J Med Genet A 130A: 340-344
32. Burman P, Ritzen EM, Lindgren AC 2001 Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev 22:787-799
33. Livingston FR, Arens R, Bailey SL, Keens TG, Ward SL 1995 Hypercapnic arousal responses in Prader-Willi syndrome. Chest 108:1627-1631
34. Alpert MA, Lambert CR, Terry BE, Cohen MV, Mukerji V, Massey CV, Hashimi MW, Panayiotou H 1995 Interrelationship of left ventricular mass, systolic function and diastolic filling in normotensive morbidly obese patients. Int J Obes Relat Metab Disord 19:550-557
35. Iacobellis G, Ribaudo MC, Leto G, Zappaterreno A, Vecci E, Di Mario U, Leonetti F 2002 Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obes Res 10:767-773
36. Ruffolo Jr RR 1987 The pharmacology of dobutamine. Am J Med Sci 294:244-248
37. Lanza GA, Guido V, Galeazzi MM, Mustilli M, Natali R, Ierardi C, Milici C, Burzotta F, Pasceri V, Tomassini F, Lupi A, Maseri A 1998 Prognostic role of heart rate variability in patients with a recent acute myocardial infarction. Am J Cardiol 82:1323-1328
38. DiMario Jr FJ, Dunham B, Burleson JA, Moskovitz J, Cassidy SB 1994 An evaluation of autonomic nervous system function in patients with Prader-Willi syndrome. Pediatrics 93:76-81
39. Wade CK, De Meersman RE, Angulo M, Lieberman JS, Downey JA 2000 Prader-Willi syndrome fails to alter cardiac autonomic modulation. Clin Auton Res 10:203-206
40. Hamilton GS, Solin P, Naughton MT 2004 Obstructive sleep apnoea and cardiovascular disease. Int Med J 34:420-426
41. Valcavi R, Gaddi O, Zini M, Iavicoli M, Mellino U, Portioli I 1995 Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. J Clin Endocrinol Metab 80:659-666
42. Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O, Revel-Chion R 2001 Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents. J Clin Endocrinol Metab 86:1061-1065
43. Colao A, Di Somma C, Cuocolo A, Filippella M, Rota F, Acampa W, Savastano S, Salvatore M, Lombardi G 2004 The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study. J Clin Endocrinol Metab 89:5998-6004.
44. Scacchi M, Pincelli AI, Cavagnini F 1999 Growth hormone in obesity. Int J Obes Relat Metab Disord 23:260-271
45. Maccario M, Gauna C, Procopio M, Di Vito L, Rossetto R, Oleandri SE, Grottoli S, Ganzaroli C, Aimaretti G, Ghigo E 1999 Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test. J Endocrinol Invest 22:424-429
46. Haqq AM, Stadler DD, Jackson RH, Rosenfeld RG, Purnell JQ, LaFranchi SH 2003 Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab 88:2206-2212